Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer

Published:2015-09-24 Issue:2 Volume:27 Page:148-152
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Vaccaro Mario,Guarneri Fabrizio,Borgia Francesco,Pollicino Andrea,Altavilla Giuseppe,Cannavò Serafinella P.

Publisher

Informa UK Limited

Subject

Dermatology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

Reference20 articles.

1. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

2. Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

3. Description and management of cutaneous side effects during cetuximab or erlotinib treatments: A prospective study of 30 patients

4. Cutaneous adverse effects of targeted therapies

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous adverse events following treatment with third-generation EGFR tyrosine kinase inhibitors;Italian Journal of Dermatology and Venereology;2024-04

2. Efficacy and safety of a fixed-dose combination of clindamycin and benzoyl peroxide in patients with acne;Klinicheskaya dermatologiya i venerologiya;2022

3. Efficacy and Safety of Modified Huang-Lian-Jie-Du Decoction Cream on Cancer Patients with Skin Side Effects Caused by EGFR Inhibition;Processes;2021-06-22

4. Relationships between quality of life and skin toxicities of epidermal growth factor receptor inhibitors in cancer patients: A literature review;Japan Journal of Nursing Science;2020-01-12

5. Update review of skin adverse events during treatment of lung cancer and colorectal carcinoma with epidermal growth receptor factor inhibitors;BioScience Trends;2018-12-31